SPECIFIC CONDITION FOR SUBSEQUENT CLOSING Clause Samples

SPECIFIC CONDITION FOR SUBSEQUENT CLOSING. With respect to the Subsequent Closing only (but not the Additional Shares Closing or the Unpurchased Shares Closing), the Company shall have entered into a clinical trial designed to generate clinical proof of concept on a compound other than QRX-101, QRX-401 and QRX411. A clinical proof of concept trial is defined as a study designed to generate data, if positive, to warrant continued development in a pivotal trial, as judged by the holders of sixty-five percent (65%) of the then outstanding Shares.